Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults

224
28
Favorite

Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults

Reuters2022-01-18

Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

224

Report

Comment（28）

themonkey
·2022-01-18
I see
Reply
1
Report
NATSUSG
·2022-01-18
[Smile]
Reply
1
Report
Mindthink
·2022-01-18
Ok
Reply
1
Report
Ken3888
·2022-01-18
K
Reply
2
Report
Huntsilencer
·2022-01-18
Up
Reply
1
Report
ivy888
·2022-01-18
Like
Reply
1
Report
JRenato
·2022-01-18
Tell me your opinion about this news...
Reply
3
Report
Tomxx
·2022-01-18
Like
Reply
4
Report
Zero_onezero
·2022-01-18
Ya
Reply
2
Report
YekGuo98
·2022-01-18
Ok
Reply
3
Report
PearlynCSY
·2022-01-18
Everywhere reporting record high cases of Omicron. US is the worst with over 1.3 million cases a day. Bad for global economic recovery
Reply
4
Report
JCKL488
·2022-01-18
Good news for many people who’re scared of vaccination
Reply
1
Report
Jkan
·2022-01-18
Ok
Reply
3
Report
Swifty
·2022-01-18
👍🏻
Reply
4
Report
0ink
·2022-01-18
Ok
Reply
3
Report
Zlatan
·2022-01-18
Ok
Reply
5
Report
Zlatan
·2022-01-18
No
Reply
4
Report
JoeKun
·2022-01-18
9k
Reply
6
Report
Pandaaa
·2022-01-18
Good. Like pls
Reply
6
Report
tks_82
·2022-01-18
Like pls
Reply
8
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2204779745?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-18 07:21","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2204779745","market":"us","top_or_hot":-1,"title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","media":"Reuters","content":"<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","article_id":"2204779745","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","pubTimestamp":1642461698,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BK4139":"生物科技","BK4548":"巴美列捷福持仓","PFE":"辉瑞","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BNTX":"BioNTech SE","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"加批准辉瑞成人新冠肺炎口服抗病毒治疗","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":1,"PFE":1},"content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9004997810,"gmtCreate":1642468241517,"gmtModify":1676533713247,"author":{"id":"3573986430688942","authorId":"3573986430688942","name":"themonkey","avatar":"https://static.tigerbbs.com/573a67d390101884216129f5c49fe8a0","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3573986430688942","idStr":"3573986430688942"},"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004997810","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004901010,"gmtCreate":1642466054933,"gmtModify":1676533712878,"author":{"id":"3582883495591005","authorId":"3582883495591005","name":"NATSUSG","avatar":"https://static.tigerbbs.com/afcd031d8203cb50aa68634c76ecd5f4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3582883495591005","idStr":"3582883495591005"},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004901010","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004075828,"gmtCreate":1642465512583,"gmtModify":1676533712722,"author":{"id":"4102837759709900","authorId":"4102837759709900","name":"Mindthink","avatar":"https://community-static.tradeup.com/news/89b965229f7209196369426d161728ee","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"4102837759709900","idStr":"4102837759709900"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004075828","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004048668,"gmtCreate":1642464356231,"gmtModify":1676533712338,"author":{"id":"3581507312795318","authorId":"3581507312795318","name":"Ken3888","avatar":"https://static.tigerbbs.com/493a96d6ecc5aa191181e04cc37afca5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581507312795318","idStr":"3581507312795318"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004048668","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004057440,"gmtCreate":1642463825403,"gmtModify":1676533712228,"author":{"id":"3583029437333652","authorId":"3583029437333652","name":"Huntsilencer","avatar":"https://static.tigerbbs.com/9b69d6b5db7ba7ec92be9ac8c5c5705c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3583029437333652","idStr":"3583029437333652"},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004057440","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004054438,"gmtCreate":1642463697124,"gmtModify":1676533712205,"author":{"id":"3579641974902127","authorId":"3579641974902127","name":"ivy888","avatar":"https://static.tigerbbs.com/10358949b7fc96b011ec29ca7fd9c9a4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3579641974902127","idStr":"3579641974902127"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004054438","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004052196,"gmtCreate":1642463553103,"gmtModify":1676533712139,"author":{"id":"3583705322747279","authorId":"3583705322747279","name":"JRenato","avatar":"https://static.tigerbbs.com/69d1d1158d9ad6393f946ff9486ab742","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583705322747279","idStr":"3583705322747279"},"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004052196","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004056652,"gmtCreate":1642463479581,"gmtModify":1676533712131,"author":{"id":"3586059298879232","authorId":"3586059298879232","name":"Tomxx","avatar":"https://static.tigerbbs.com/abd49c57222b3b842f3f9af84b9d5b97","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3586059298879232","idStr":"3586059298879232"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004056652","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004056074,"gmtCreate":1642463398152,"gmtModify":1676533712107,"author":{"id":"3581743394055717","authorId":"3581743394055717","name":"Zero_onezero","avatar":"https://static.tigerbbs.com/f93660d80ec28ae67a094cb5c0c44350","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3581743394055717","idStr":"3581743394055717"},"htmlText":"Ya","listText":"Ya","text":"Ya","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004056074","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004051619,"gmtCreate":1642463123556,"gmtModify":1676533712068,"author":{"id":"3581548914971628","authorId":"3581548914971628","name":"YekGuo98","avatar":"https://static.tigerbbs.com/6bdd5398a1a15dc43469cee5e6b364b4","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3581548914971628","idStr":"3581548914971628"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004051619","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004025718,"gmtCreate":1642462560819,"gmtModify":1676533711875,"author":{"id":"4092458811577680","authorId":"4092458811577680","name":"PearlynCSY","avatar":"https://static.tigerbbs.com/b3e9fe7af061efe80a756d23de62e7b3","vip":1,"crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"4092458811577680","idStr":"4092458811577680"},"htmlText":"Everywhere reporting record high cases of Omicron. US is the worst with over 1.3 million cases a day. Bad for global economic recovery","listText":"Everywhere reporting record high cases of Omicron. US is the worst with over 1.3 million cases a day. Bad for global economic recovery","text":"Everywhere reporting record high cases of Omicron. US is the worst with over 1.3 million cases a day. Bad for global economic recovery","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004025718","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004025278,"gmtCreate":1642462509423,"gmtModify":1676533711947,"author":{"id":"3574736103389937","authorId":"3574736103389937","name":"JCKL488","avatar":"https://static.tigerbbs.com/b46f479e98d6cf2484ad9c767786e663","vip":1,"crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3574736103389937","idStr":"3574736103389937"},"htmlText":"Good news for many people who’re scared of vaccination&nbsp;","listText":"Good news for many people who’re scared of vaccination&nbsp;","text":"Good news for many people who’re scared of vaccination","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004025278","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004028749,"gmtCreate":1642462212813,"gmtModify":1676533711804,"author":{"id":"3574381604982902","authorId":"3574381604982902","name":"Jkan","avatar":"https://static.tigerbbs.com/9e5803c697580c21a815764131d05679","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574381604982902","idStr":"3574381604982902"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004028749","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004028653,"gmtCreate":1642462155496,"gmtModify":1676533711796,"author":{"id":"3573686260747225","authorId":"3573686260747225","name":"Swifty","avatar":"https://static.tigerbbs.com/25bc2f32857ae0c620f1d9eee6447454","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573686260747225","idStr":"3573686260747225"},"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004028653","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004028822,"gmtCreate":1642462135581,"gmtModify":1676533711828,"author":{"id":"3582069515093971","authorId":"3582069515093971","name":"0ink","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582069515093971","idStr":"3582069515093971"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004028822","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004028149,"gmtCreate":1642462129844,"gmtModify":1676533711795,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","vip":1,"crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3586734124712023","idStr":"3586734124712023"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004028149","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004028388,"gmtCreate":1642462119738,"gmtModify":1676533711789,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","vip":1,"crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3586734124712023","idStr":"3586734124712023"},"htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004028388","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004021541,"gmtCreate":1642462086775,"gmtModify":1676533711781,"author":{"id":"4087524360121530","authorId":"4087524360121530","name":"JoeKun","avatar":"https://static.tigerbbs.com/a543b7a138549431b97b6bee2bc9e956","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4087524360121530","idStr":"4087524360121530"},"htmlText":"9k","listText":"9k","text":"9k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004021541","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004021252,"gmtCreate":1642462082059,"gmtModify":1676533711787,"author":{"id":"4098058289318030","authorId":"4098058289318030","name":"Pandaaa","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4098058289318030","idStr":"4098058289318030"},"htmlText":"Good. Like pls","listText":"Good. Like pls","text":"Good. Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004021252","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9004021947,"gmtCreate":1642462052580,"gmtModify":1676533711770,"author":{"id":"3581754084854007","authorId":"3581754084854007","name":"tks_82","avatar":"https://community-static.tradeup.com/news/3547658cb0a496157138bc30326aa3d7","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":1,"crmLevelSwitch":1,"authorIdStr":"3581754084854007","idStr":"3581754084854007"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004021947","repostId":2204779745,"repostType":4,"repost":{"id":"2204779745","kind":"news","pubTimestamp":1642461698,"share":"https://ttm.financial/m/news/2204779745?lang=&edition=fundamental","pubTime":"2022-01-18 07:21","market":"us","language":"en","title":"Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2204779745","media":"Reuters","summary":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of C","content":"<html><head></head><body><p>Canada on Monday approved Pfizer Inc&#39;s oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada&#39;s website.</p><p>Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.</p><p>Pfizer&#39;s antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company&#39;s clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p><p>Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.</p><p>The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Canada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCanada Approves Pfizer's COVID-19 Oral Antiviral Treatment for Adults\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4007":"制药","BK4548":"巴美列捷福持仓","BNTX":"BioNTech SE","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓"},"source_url":"https://finance.yahoo.com/news/1-canada-approves-pfizers-covid-153721842.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2204779745","content_text":"Canada on Monday approved Pfizer Inc's oral antiviral treatment to treat mild to moderate cases of COVID-19 in people aged 18 and older, according to a notice posted on Health Canada's website.Cases and hospitalisations due the Omicron variant has been rising in Canada, forcing provinces to put restrictions and the federal government to support impacted businesses.Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.The U.S. authorized the treatment for people ages 12 and older last month. (Reporting by David Ljunggren. Editing by Franklin Paul)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":224,"commentSize":28,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}